Lista de obras - Nikos Evangelou - Dominio Público Uruguay

3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions

scientific article published on 01 October 2010

A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions.

artículo científico publicado en 2009

A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field

artículo científico publicado en 2016

Aggressive multiple sclerosis (1): Towards a definition of the phenotype

artículo científico publicado en 2020

Aggressive multiple sclerosis (2): Treatment

artículo científico publicado en 2020

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial

artículo científico publicado en 2015

Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial

artículo científico publicado en 2017

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

artículo científico publicado en 2013

Anatomy of the Retina and the Optic Nerve

Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial

artículo científico publicado en 2015

Association between pathological and MRI findings in multiple sclerosis

artículo científico publicado en 2012

Behavioural activation treatment for depression in individuals with neurological conditions: a systematic review

artículo científico publicado en 2019

Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab

artículo científico publicado en 2014

Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.

artículo científico publicado en 2013

Clinical observation during alemtuzumab administration

scientific article published on 25 September 2019

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

artículo científico publicado en 2010

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.

artículo científico publicado en 2007

Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter

artículo científico publicado en 2013

Detection of central vein should be part of MS diagnostic criteria - Yes

scientific article published on 03 March 2020

Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners

scientific article published in 2021

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

artículo científico publicado en 2013

Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis

artículo científico publicado en 2019

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

artículo científico publicado en 2020

Focal multiple sclerosis lesions abound in 'normal appearing white matter'.

artículo científico publicado en 2011

Headache: two views on the right approach in general practice.

artículo científico publicado en 2014

Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.

artículo científico publicado en 2015

Imaging gray matter with concomitant null point imaging from the phase sensitive inversion recovery sequence

artículo científico publicado en 2015

Improved detection of focal cortical lesions using 7T magnetisation transfer imaging in patients with multiple sclerosis.

artículo científico publicado en 2013

Lymphocyte counts and the risk of COVID-19 in people with MS

artículo científico publicado en 2020

Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.

artículo científico publicado en 2015

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

artículo científico publicado en 2016

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

artículo científico publicado en 2013

Measurement of spinal cord atrophy in multiple sclerosis

artículo científico publicado en 2004

Multiple Sclerosis

Multiple sclerosis findings in the spinal cord.

artículo científico publicado en 2007

New imaging language skills required in MS.

artículo científico publicado en 2015

Optimisation of T₂*-weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T.

artículo científico publicado en 2011

Postpartum headache: diagnostic considerations.

artículo científico publicado en 2013

Pragmatic clinical trials for treating relapsing multiple sclerosis

artículo científico publicado en 2019

Primary care direct access MRI for the investigation of chronic headache.

artículo científico publicado en 2011

Prognostication and contemporary management of clinically isolated syndrome

artículo científico publicado en 2020

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

article

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

scientific article published in The Lancet

Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom

scholarly article by Trudy Owens published in January 2012

Role of oral teriflunomide in the management of multiple sclerosis.

artículo científico publicado en 2013

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

scientific article published on 05 July 2019

Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty

scientific article published on 31 October 2019

Spinal Cord Atrophy in Multiple Sclerosis Caused by White Matter Volume Loss

article by Christopher P. Gilmore et al published 1 December 2005 in Archives of Neurology

Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology

artículo científico publicado en 2006

Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging

artículo científico publicado en 2008

Spinal cord neuronal pathology in multiple sclerosis

artículo científico publicado en 2008

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

artículo científico publicado en 2015

Subjective discomfort in children receiving 3 T MRI and experienced adults' perspective on children's tolerability of 7 T: a cross-sectional questionnaire survey

artículo científico publicado en 2014

Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms

scientific article published on 05 September 2018

The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

artículo científico publicado en 2018

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

artículo científico publicado en 2018

The current state-of-the-art of spinal cord imaging: methods.

artículo científico

The only way to manage neurodegeneration in MS is to prevent it with effective anti-inflammatory therapy: yes

artículo científico publicado en 2012

Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom

artículo científico publicado en 2016

Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis

scientific article published on 21 May 2020

Lista de obras de Nikos Evangelou

3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions

A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions.

A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field

Aggressive multiple sclerosis (1): Towards a definition of the phenotype

Aggressive multiple sclerosis (2): Treatment

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial

Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Anatomy of the Retina and the Optic Nerve

Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial

Association between pathological and MRI findings in multiple sclerosis

Behavioural activation treatment for depression in individuals with neurological conditions: a systematic review

Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab

Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.

Clinical observation during alemtuzumab administration

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.

Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter

Detection of central vein should be part of MS diagnostic criteria - Yes

Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Focal multiple sclerosis lesions abound in 'normal appearing white matter'.

Headache: two views on the right approach in general practice.

Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.

Imaging gray matter with concomitant null point imaging from the phase sensitive inversion recovery sequence

Improved detection of focal cortical lesions using 7T magnetisation transfer imaging in patients with multiple sclerosis.

Lymphocyte counts and the risk of COVID-19 in people with MS

Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

Measurement of spinal cord atrophy in multiple sclerosis

Multiple Sclerosis

Multiple sclerosis findings in the spinal cord.

New imaging language skills required in MS.

Optimisation of T₂*-weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T.

Postpartum headache: diagnostic considerations.

Pragmatic clinical trials for treating relapsing multiple sclerosis

Primary care direct access MRI for the investigation of chronic headache.

Prognostication and contemporary management of clinically isolated syndrome

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom

Role of oral teriflunomide in the management of multiple sclerosis.

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty

Spinal Cord Atrophy in Multiple Sclerosis Caused by White Matter Volume Loss

Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology

Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging

Spinal cord neuronal pathology in multiple sclerosis

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

Subjective discomfort in children receiving 3 T MRI and experienced adults' perspective on children's tolerability of 7 T: a cross-sectional questionnaire survey

Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms

The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

The current state-of-the-art of spinal cord imaging: methods.

The only way to manage neurodegeneration in MS is to prevent it with effective anti-inflammatory therapy: yes

Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom

Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis